China Pharma Holdings, Inc.
CPHI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40,690 | $64,127 | $252,329 | $1,113,100 |
| - Cash | $627 | $1,424 | $2,030 | $4,859 |
| + Debt | $3,591 | $4,634 | $8,757 | $12,488 |
| Enterprise Value | $43,655 | $67,337 | $259,057 | $1,120,729 |
| Revenue | $4,529 | $7,011 | $8,104 | $9,642 |
| % Growth | -35.4% | -13.5% | -15.9% | – |
| Gross Profit | -$1,986 | -$281 | -$494 | $349 |
| % Margin | -43.8% | -4% | -6.1% | 3.6% |
| EBITDA | -$1,964 | $8 | -$838 | $230 |
| % Margin | -43.4% | 0.1% | -10.3% | 2.4% |
| Net Income | -$4,736 | -$3,079 | -$3,973 | -$3,399 |
| % Margin | -104.6% | -43.9% | -49% | -35.3% |
| EPS Diluted | -0.27 | -0.29 | -1.94 | -0.85 |
| % Growth | 6.9% | 85.1% | -128.2% | – |
| Operating Cash Flow | -$466 | -$700 | -$410 | -$250 |
| Capital Expenditures | -$292 | -$12 | -$402 | -$438 |
| Free Cash Flow | -$758 | -$711 | -$812 | -$688 |